Skip to main content
Fig. 1 | Cancer Nanotechnology

Fig. 1

From: Evaluation of the performance of Fe3O4/MnO2@doxorubicin hybrid nanozymes on multicellular structure and their therapeutic management to limit the growth of human breast cancer cells

Fig. 1

Characterizations of the FMDHN. A SEM images of FMHN and B FMDHN. C TEM images of FMDHN. D the size distribution and E N2 adsorption–desorption isotherms [F The size of pores on FMHN is indicated by the inset] of FMHN. G Zeta potential values of Fe3O4 nanozymes and FMHN. H XRD patterns of the synthesized Fe3O4 nanozymes and FMHN

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us